Metabolic syndrome frequency in inflammatory bowel diseases
Background/Aim: Metabolic syndrome (MetS) is a clinical condition characterized by central obesity, elevated triglycerides, low-high density lipoproteins, impaired fasting glucose, and hypertension. There is insufficient data on the prevalence of MetS in patients with inflammatory bowel disease (IBD...
Main Authors: | Elif Yorulmaz, Gupse Adali, Hatice Yorulmaz, Celal Ulasoglu, Guralp Tasan, Ilyas Tuncer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2011-01-01
|
Series: | The Saudi Journal of Gastroenterology |
Subjects: | |
Online Access: | http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2011;volume=17;issue=6;spage=376;epage=382;aulast=Yorulmaz |
Similar Items
-
Evaluating the Impact of Obesity and Different Metabolic Statuses on the Prognosis of Hospitalized Patients with Inflammatory Bowel Disease: A Cohort Study
by: Yanyan Wang, et al.
Published: (2023-08-01) -
Connecting the Dots Between Inflammatory Bowel Disease and Metabolic Syndrome: A Focus on Gut-Derived Metabolites
by: Andrea Verdugo-Meza, et al.
Published: (2020-05-01) -
Changing phenotype of inflammatory bowel disease and neglected metabolic health
by: John O’Grady, et al.
Published: (2021-01-01) -
Metabolic nanoregulator remodels gut microenvironment for treatment of inflammatory bowel disease
by: Xu, Ting, et al.
Published: (2024) -
Examining the influence of inflammatory bowel disease medications on sleep quality
by: Alex Barnes, et al.
Published: (2023-03-01)